Toward individualized cholesterol-lowering treatment in end-stage renal disease

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Metabolic Disorders

Background:

• Lowering low-density lipoprotein (LDL) cholesterol reduces cardiovascular risk in the general population.
• However, LDL cholesterol reduction is less effective for preventing cardiovascular complications in patients undergoing maintenance hemodialysis.
• This reduced efficacy may be linked to high cholesterol absorption in this patient group.

Purpose of the Study:

• To review cholesterol homeostasis in patients on maintenance hemodialysis.
• To explore the reduced effectiveness of LDL cholesterol lowering in this population.
• To discuss personalized treatment strategies for hypercholesterolemia in hemodialysis patients.

Main Methods:

• Literature review of studies on cholesterol metabolism and cardiovascular risk in hemodialysis patients.
• Analysis of factors influencing cholesterol homeostasis, including synthesis and absorption.
• Discussion of therapeutic interventions targeting intestinal cholesterol absorption.

Main Results:

• Patients on maintenance hemodialysis exhibit high intestinal cholesterol absorption.
• Statins may have a less pronounced benefit in individuals with high cholesterol absorption.
• Alternative or complementary strategies are needed for managing hypercholesterolemia in this population.

Conclusions:

• Dietary counseling to reduce cholesterol intake is recommended.
• Functional foods with plant sterols and stanols may be beneficial.
• Drugs interfering with intestinal sterol absorption (e.g., ezetimibe, bile acid resins, sevelamer) offer a promising therapeutic avenue.